Hudson Technologies Inc /Ny
HDSN Nasdaq Wholesale-Machinery, Equipment & Supplies Financials FY2016βFY2025
What Hudson Technologies Inc /Ny does
No business description yet.
- Legal name
- HUDSON TECHNOLOGIES INC /NY
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 16, 2026
- Accession Β· CIK
- 0001104659-26-028445
0000925528
Revenue and margins
Hudson Technologies Inc /Ny had $247M of revenue in fiscal 2025, up 4.0% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 2.4% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$8.2M in fiscal 2025, β3.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Hudson Technologies Inc /Ny returned $20.0M to shareholders in fiscal 2025. The diluted share count fell 4.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Hudson Technologies Inc /Ny can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $3.5M | $5.3M | $12.4M | $70.1M | $39.5M |
| Debt incl. finance leases | $93.4M | $47.5M | β | β | β |
| Net debt / EBITDA | 2.0x | 0.3x | β | β | β |
| Debt / equity | 1.3x | 0.3x | β | β | β |
| Interest coverage | 3.7x | 9.2x | 9.4x | β | β |
| Current ratio | 1.9x | 3.4x | 3.5x | 4.1x | 3.3x |
| Quick ratio | 0.4x | 0.6x | 0.9x | 2.1x | 1.2x |
| Total assets | $216M | $272M | $297M | $303M | $319M |
| Total liabilities | $145M | $97.6M | $67.9M | $56.8M | $75.3M |
| Shareholders' equity | $70.9M | $175M | $229M | $246M | $243M |
| Net debt (β = net cash) | $89.9M | $42.2M | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 3 / 9 | 4 / 9 | 6 / 9 | 7 / 9 | 5 / 9 | 7 / 9 | 4 / 8 | 5 / 8 | 2 / 8 |
| Accruals ratio | 1.1% | β3.2% | β33.5% | β29.3% | β9.9% | 17.7% | 16.8% | β2.2% | β22.5% | 6.4% |
| Altman Z'' | 17.47 | 3.38 | 0.35 | β0.53 | 0.01 | 2.83 | 8.81 | 9.76 | 9.85 | 8.35 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $105M | $140M | $167M | $162M | $148M | $193M | $325M | $289M | $237M | $247M |
| Gross profit | $31.1M | $38.0M | β$7.4M | $17.2M | $35.4M | $71.7M | $163M | $112M | $65.7M | $62.1M |
| Operating income | $18.9M | $15.1M | β$42.6M | β$15.8M | $5.9M | $42.3M | $132M | $78.2M | $29.3M | $18.6M |
| Interest expense | $1.1M | $3.2M | $14.8M | $18.9M | $12.3M | $11.4M | $14.3M | $8.4M | β | β |
| Pretax income | $17.3M | $12.0M | β$57.4M | β$25.3M | β$5.4M | $33.4M | $117M | $69.8M | $32.0M | $22.7M |
| Income tax | $6.6M | $0.8M | β$1.7M | $0.7M | β$0.2M | $1.1M | $13.4M | $17.6M | $7.6M | $6.0M |
| Net income | $10.6M | $11.2M | β$55.7M | β$25.9M | β$5.2M | $32.3M | $104M | $52.2M | $24.4M | $16.7M |
| Diluted EPS | $0.30 | $0.26 | β$1.31 | β$0.61 | β$0.12 | $0.69 | $2.20 | $1.10 | $0.52 | $0.37 |
| Diluted shares | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B |
| Cash flow | ||||||||||
| Cash from operations | $9.3M | $18.4M | $36.3M | $33.8M | $11.7M | β$1.2M | $62.8M | $58.5M | $91.8M | β$3.2M |
| Capital expenditure | $1.7M | $1.0M | $1.1M | $1.0M | $1.5M | $1.9M | $3.7M | $3.6M | $5.3M | $5.1M |
| Free cash flow | $7.6M | $17.3M | $35.2M | $32.8M | $10.2M | β$3.2M | $59.2M | $55.0M | $86.5M | β$8.2M |
| Depreciation and amortization | $1.7M | $2.3M | $4.2M | $4.2M | $3.2M | $3.4M | $3.2M | $3.0M | $3.0M | $2.7M |
| Stock-based compensation | $0.7M | $1.5M | $1.4M | $1.8M | $0.7M | $0.5M | $0.9M | $2.3M | $0.8M | $1.1M |
| Share buybacks | β | β | β | β | β | β | β | β | $8.1M | $20.0M |
| Dividends and buybacks | β | β | β | β | β | β | β | β | $8.1M | $20.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $33.9M | $5.0M | $2.3M | $2.6M | $1.3M | $3.5M | $5.3M | $12.4M | $70.1M | $39.5M |
| Total debt | $0.6M | $167M | $130M | $99.0M | $87.3M | $93.4M | $47.5M | β | β | β |
| Current assets | $108M | $209M | $124M | $74.4M | $62.1M | $120M | $177M | $205M | $196M | $211M |
| Current liabilities | $10.3M | $95.4M | $60.4M | $46.1M | $37.8M | $64.4M | $52.6M | $58.6M | $47.8M | $64.6M |
| Inventory | $68.6M | $172M | $102M | $59.2M | $44.5M | $94.1M | $145M | $154M | $96.2M | $136M |
| Property and equipment, net | $7.5M | $30.5M | $27.4M | $23.7M | $21.9M | $20.1M | $20.6M | $19.4M | $21.6M | $23.6M |
| Goodwill | $0.9M | $49.5M | $47.8M | $47.8M | $47.8M | $47.8M | $47.8M | $47.8M | $62.3M | $65.3M |
| Intangible assets | $3.3M | $32.4M | $29.5M | $26.0M | $23.2M | $20.4M | $17.6M | $14.8M | $14.1M | $11.3M |
| Total assets | $122M | $321M | $228M | $180M | $162M | $216M | $272M | $297M | $303M | $319M |
| Total liabilities | $10.5M | $198M | $159M | $135M | $121M | $145M | $97.6M | $67.9M | $56.8M | $75.3M |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | β | β | β | β |
| Shareholders' equity | $112M | $123M | $69.2M | $45.1M | $40.6M | $70.9M | $175M | $229M | $246M | $243M |
| Margins | ||||||||||
| Gross margin | 29.5% | 27.1% | β4.4% | 10.6% | 24.0% | 37.2% | 50.1% | 38.6% | 27.7% | 25.2% |
| Operating margin | 18.0% | 10.8% | β25.6% | β9.7% | 4.0% | 21.9% | 40.4% | 27.0% | 12.4% | 7.5% |
| EBITDA margin | 19.6% | 12.4% | β23.1% | β7.2% | 6.2% | 23.7% | 41.4% | 28.1% | 13.6% | 8.6% |
| Net margin | 10.1% | 7.9% | β33.4% | β16.0% | β3.5% | 16.7% | 31.9% | 18.1% | 10.3% | 6.8% |
| FCF margin | 7.2% | 12.4% | 21.2% | 20.2% | 6.9% | β1.6% | 18.2% | 19.0% | 36.5% | β3.3% |
| Returns | ||||||||||
| Return on capital | 15.7% | 4.9% | β17.1% | β8.8% | 3.7% | 25.4% | 53.7% | β | β | β |
| Return on capital employed | 16.9% | 6.7% | β25.4% | β11.8% | 4.8% | 28.0% | 59.8% | 32.8% | 11.5% | 7.3% |
| Return on equity | 9.5% | 9.5% | β57.8% | β45.4% | β12.1% | 57.8% | 84.5% | 25.9% | 10.3% | 6.8% |
| Return on assets | 8.7% | 5.0% | β20.2% | β12.7% | β3.0% | 17.1% | 42.5% | 18.4% | 8.1% | 5.4% |
| Return on tangible equity | 9.9% | 26.8% | β | β | β | 1,160.8% | 94.8% | 31.4% | 14.4% | 10.0% |
| Growth | ||||||||||
| Revenue growth | β | 33.1% | 18.6% | β2.7% | β8.9% | 30.6% | 68.7% | β11.1% | β18.0% | 4.0% |
| Net income growth | β | 4.9% | β598.9% | β | β | β | 221.8% | β49.7% | β53.3% | β31.7% |
| EPS growth | β | β13.3% | β603.8% | β | β | β | 218.8% | β50.0% | β52.7% | β28.8% |
| FCF growth | β | 127.8% | 103.2% | β6.9% | β68.9% | β130.8% | β | β7.1% | 57.4% | β109.5% |
| Share count change | β | 20.8% | β0.7% | 0.3% | 0.2% | 9.2% | 1.0% | 0.5% | β0.6% | β4.2% |
| Financial health | ||||||||||
| Net debt / EBITDA | β1.6x | 9.3x | β | β | 9.4x | 2.0x | 0.3x | β | β | β |
| Debt / equity | 0.0x | 1.4x | 1.9x | 2.2x | 2.1x | 1.3x | 0.3x | β | β | β |
| Interest coverage | 16.9x | 4.8x | β2.9x | β0.8x | 0.5x | 3.7x | 9.2x | 9.4x | β | β |
| Current ratio | 10.5x | 2.2x | 2.0x | 1.6x | 1.6x | 1.9x | 3.4x | 3.5x | 4.1x | 3.3x |
| Quick ratio | 3.8x | 0.4x | 0.4x | 0.3x | 0.5x | 0.4x | 0.6x | 0.9x | 2.1x | 1.2x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.6% | 0.7% | 0.7% | 0.6% | 1.0% | 1.0% | 1.1% | 1.2% | 2.2% | 2.0% |
| Stock comp / revenue | 0.7% | 1.1% | 0.8% | 1.1% | 0.4% | 0.3% | 0.3% | 0.8% | 0.4% | 0.4% |
| Payouts / FCF | β | β | β | β | β | β | β | β | 9.4% | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 3.0 | 4.0 | 6.0 | 7.0 | 5.0 | 7.0 | 4.0 | 5.0 | 2.0 |
| Altman Z'' | 17.5 | 3.4 | 0.3 | β0.5 | 0.0 | 2.8 | 8.8 | 9.8 | 9.8 | 8.3 |
| Accruals ratio | 1.1% | β3.2% | β33.5% | β29.3% | β9.9% | 17.7% | 16.8% | β2.2% | β22.5% | 6.4% |
Source: SEC EDGAR XBRL filings (CIK 0000925528). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.